#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4292	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2124	377.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1512	1512	C	500	C	318	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8530	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3628	444.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1812	1812	A	478	A	319	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8530	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3628	444.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2446	2446	C	456	C	304	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8530	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3628	444.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2520	2520	A	479	A	306	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8530	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3628	444.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3072	3072	C	538	C	357	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	700	folP	855	855	100.0	folP.l15.c4.ctg.1	1621	81.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1017	1019	AGC	98;102;102	A;G;C	64;67;67	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1554	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3452	85.5	1	SNP	p	S91F	1	.	.	271	273	TTC	709	711	TTC	81;81;81	T;T;C	51;52;52	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1554	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3452	85.5	1	SNP	p	G95N	0	.	.	283	285	GGC	721	723	GGC	92;93;93	G;G;C	59;59;58	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1554	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3452	85.5	1	SNP	p	D95G	1	.	.	283	285	GGC	721	723	GGC	92;93;93	G;G;C	59;59;58	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	456	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1464	63.3	1	SNP	p	G45D	0	.	.	133	135	GGC	602	604	GGC	125;125;125	G;G;C	79;80;77	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	306	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1081	53.8	0	.	n	.	0	A197.	DEL	197	197	A	554	554	A	119	A	77	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1276	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2879	85.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1494	1496	GTC	70;71;70	G;T,G,A;C	52;50,1,1;51	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1276	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2879	85.9	1	SNP	p	D86N	0	.	.	256	258	GAC	600	602	GAC	115;114;114	G;A,T;C	73;68,1;75	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1276	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2879	85.9	1	SNP	p	R87W	0	.	.	259	261	CGT	603	605	CGT	113;113;111	C;G;T	78;74;78	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1276	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2879	85.9	1	SNP	p	S87R	1	.	.	259	261	CGT	603	605	CGT	113;113;111	C;G;T	78;74;78	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1276	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2879	85.9	1	SNP	p	R87I	0	.	.	259	261	CGT	603	605	CGT	113;113;111	C;G;T	78;74;78	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1276	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2879	85.9	1	SNP	p	S88P	0	.	.	262	264	TCC	606	608	TCC	111;113;113	T,C;C,T;C	78,1;79,2;81	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1400	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2546	106.1	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1308	1310	TGC	130;130;130	T,G,C;G;C,T	85,2,1;88;86,2	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1400	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2546	106.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	96;96;96	G;G,T;C	69;64,1;64	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1485	1487	GCA	168;171;171	G;C;A	112;112;111	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1488	1490	ATC	169;169;169	A;T;C	111;112;112	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1500	1502	GTG	168;168;168	G;T;G	112;111;112	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1500	1502	GTG	168;168;168	G;T;G	112;111;112	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2004	2006	ACC	95;95;93	A;C;C	66;69;69	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2058	2060	GCG	82;82;82	G;C,G;G,T	55;52,1;56,1	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2058	2060	GCG	82;82;82	G;C,G;G,T	55;52,1;56,1	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2181	2183	GGC	90;90;91	G;G,A;C,G,T	63;63,1;63,1,1	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2190	2192	GGC	73;73;73	G;G;C	54;53;47	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1352	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2512	102.7	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2208	2210	TCG	71;71;71	T,G;C,T;G	43,5;46,1;52	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1802	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3308	99.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1808	1810	CCG	69;69;69	C,A;C,A;G	48,1;50,1;50	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	610	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1755	66.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	483	483	C	62	C	35	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	247	249	AAT	7;7;7	A;A;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	250	252	AAT	7;7;6	A;A;T	4;4;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	274	276	GCA	6;6;6	G;C;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	297	299	GTA	6;5;5	G;T;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	S236N	NONSYN	706	708	AGC	303	305	AAC	5;5;5	A;A;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	.	MULTIPLE	709	711	AAC	307	311	TGGCG	5;5;5;5;5	T;G;G;C;G	3;3;3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	D238A	NONSYN	712	714	GAT	313	315	GCT	6;6;6	G;C;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	373	375	TTA	7;7;7	T;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	418	420	CAT	5;5;5	C;A;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	421	423	AGT	5;5;5	A;G;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	48	porB1a	984	297	90.37	porB1a.l15.c4.ctg.2	520	5.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	430	432	TAC	5;5;5	T;A;C	4;4;4	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	606	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1896	61.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	566	568	GAA	89;89;89	G,A;A;A	58,1;59;59	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	606	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1896	61.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	854	856	GAT	88;88;88	G;A;T	60;59;59	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	606	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1896	61.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	977	979	TCA	95;95;95	T;C;A	62;60;63	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	606	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1896	61.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1106	1108	GTC	89;91;92	G,T;T;C,G	54,1;60;60,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	606	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1896	61.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1436	1438	GCA	86;84;84	G;C;A	55;53;53	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	606	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1896	61.5	1	SNP	p	G120K	1	.	.	358	360	AAG	812	814	AAG	86;86;88	A;A;G	60;60;61	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	606	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1896	61.5	1	SNP	p	D121N	0	.	.	361	363	GAC	815	817	GAC	89;89;89	G,A;A,T;C	60,1;60,1;60	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	606	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1896	61.5	1	SNP	p	A121D	1	.	.	361	363	GAC	815	817	GAC	89;89;89	G,A;A,T;C	60,1;60,1;60	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	116	92.24	porB3.l15.c4.ctg.1	479	7.3	0	.	p	.	0	M18T	NONSYN	52	54	ATG	400	402	ACG	14;14;14	A;C;G	9;9;9	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	116	92.24	porB3.l15.c4.ctg.1	479	7.3	0	.	p	.	0	T29A	NONSYN	85	87	ACC	433	435	GCC	13;13;13	G;C;C	9;9;9	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	116	92.24	porB3.l15.c4.ctg.1	479	7.3	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	442	444	CAA	7;7;6	C;A;A	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	116	92.24	porB3.l15.c4.ctg.1	479	7.3	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	448	450	TAC	6;5;5	T;A;C	5;4;4	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	205	92.68	porB3.l15.c4.ctg.2	209	3.6	0	.	p	.	0	L253A	NONSYN	757	759	TTG	41	43	GCG	2;2;2	G;C;G	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	205	92.68	porB3.l15.c4.ctg.2	209	3.6	0	.	p	.	0	V260L	NONSYN	778	780	GTA	62	64	TTA	4;4;4	T;T;A	2;2;2	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	205	92.68	porB3.l15.c4.ctg.2	209	3.6	0	.	p	.	0	D275H	NONSYN	823	825	GAT	107	109	CAT	2;2;2	C;A;T	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	205	92.68	porB3.l15.c4.ctg.2	209	3.6	0	.	p	.	0	D276S	NONSYN	826	828	GAT	110	112	AGT	2;2;2	A;G;T	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	205	92.68	porB3.l15.c4.ctg.2	209	3.6	0	.	p	.	0	K278D	NONSYN	832	834	AAA	116	118	GAC	2;2;2	G;A;C	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	26	porB3	990	205	92.68	porB3.l15.c4.ctg.2	209	3.6	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	119	121	TAC	2;2;2	T;A;C	1;1;1	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1926	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	5114	72.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2042	2044	AAT	89;89;88	A;A;T	58;58;58	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	178	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1212	30.6	1	SNP	p	V57M	1	.	.	169	171	ATG	545	547	ATG	60;59;60	A;T;G	41;40;41	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
